Isabel Lozano Fernandez
Chief Executive Officer chez ATRYS HEALTH, S.A.
Profil
Isabel Lozano Fernandez is currently the Chief Executive Officer & Executive Director at Atrys Health SA since 2007.
She is also the Chief Executive Officer at Instituto De Estudios Celulares Y Moleculares Icm SA and Director at Instituto Biomar SA. Previously, she worked as the Chief Executive Officer at Pharma Mar SA and as the Chief Financial Officer at Zeltia SA.
Postes actifs de Isabel Lozano Fernandez
| Sociétés | Poste | Début |
|---|---|---|
| ATRYS HEALTH, S.A. | Chief Executive Officer | 13/06/2007 |
Instituto Biomar SA
 Instituto Biomar SA BiotechnologyHealth Technology Instituto Biomar SL is a biotechnology company engaged in the discovery and development of marine microorganisms. It also provides clients with research, assay screening, compound analysis, and DNA and RNA sequencing services. The company was founded by Jose Luis Fernandez Puente in 1996 and is headquartered in León, Spain. | Director/Board Member | - |
Instituto De Estudios Celulares Y Moleculares Icm SA
 Instituto De Estudios Celulares Y Moleculares Icm SA Miscellaneous Commercial ServicesCommercial Services Instituto De Estudios Celulares Y Moleculares Icm SA engages in providing genetic investigation and analytical services. It offers gene testing, screening, and sequencing to ascertain an individual's pathological condition. It sells tests including TrainMee, genetic analysis of nutritional metabolism, test carriers of monogenic diseases, newborn screening for metabolopathies, and expanded panel examinations for diabetes, food intolerances, and breast and ovarian cancer. The firm also maintains a bioinformatics unit that stores genetic data that it examines. The company was founded on 1997 and is headquartered in Lugo, Spain. | Chief Executive Officer | - |
Anciens postes connus de Isabel Lozano Fernandez
| Sociétés | Poste | Fin |
|---|---|---|
| ZELTIA SA | Director of Finance/CFO | - |
| PHARMA MAR, S.A. | Chief Executive Officer | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PHARMA MAR, S.A. | Health Technology |
| ATRYS HEALTH, S.A. | Health Services |
| Entreprise privées | 3 |
|---|---|
Zeltia SA
 Zeltia SA BiotechnologyHealth Technology Zeltia SA is a holding company, which develops marine-based drugs in the field of oncology. It operates through the Biopharmaceuticals and Consumer Chemicals segments. The Biopharmaceuticals segment engages in the research and marketing of anti-tumor drugs, diagnosis kits, and development of therapies based on reducing or silencing gene expression. The Consumer Chemicals segment produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and related products. The company was founded on August 3, 1939 and is headquartered in Madrid, Spain. | Health Technology |
Instituto Biomar SA
Instituto Biomar SA BiotechnologyHealth Technology Instituto Biomar SL is a biotechnology company engaged in the discovery and development of marine microorganisms. It also provides clients with research, assay screening, compound analysis, and DNA and RNA sequencing services. The company was founded by Jose Luis Fernandez Puente in 1996 and is headquartered in León, Spain. | Health Technology |
Instituto De Estudios Celulares Y Moleculares Icm SA
Instituto De Estudios Celulares Y Moleculares Icm SA Miscellaneous Commercial ServicesCommercial Services Instituto De Estudios Celulares Y Moleculares Icm SA engages in providing genetic investigation and analytical services. It offers gene testing, screening, and sequencing to ascertain an individual's pathological condition. It sells tests including TrainMee, genetic analysis of nutritional metabolism, test carriers of monogenic diseases, newborn screening for metabolopathies, and expanded panel examinations for diabetes, food intolerances, and breast and ovarian cancer. The firm also maintains a bioinformatics unit that stores genetic data that it examines. The company was founded on 1997 and is headquartered in Lugo, Spain. | Commercial Services |
